Title: Impact of outpatient radiotherapy on direct non-medical cost in patients in the Central Macro Region of Peru 2021
Authors: José Fernando Robles Díaz
Section: Conflicts of interest
de los indicadores de empleo e ingresos por departamento, 2007-2017 [Internet] (Lima: INEI) [https://www.inei.gob.pe/media/MenuRecursivo/publicaciones_digitales/Est/Lib1537/cap10.pdf] Date accessed: 18/07/22 15. Lin CC, Bruinooge SS, and Kirkwood MK, et al (2016) Association between geographic access to cancer care and receipt of radiation therapy for rectal cancer Int J Radiat Oncol Biol Phys 94(4) 719–728 https://doi.org/10.1016/j.ijrobp.2015.12.012 PMID: 26972644 PMCID: 5024783 16. Sharpless NE (2020) COVID-19 and cancer Science 368(6497) 1290 https://doi.org/10.1126/science.abd3377 17. Butala AA, Williams GR, and Fontanilla HP, et al (2020) Making the most of a crisis: a proposal for network-based palliative radiation therapy to reduce travel toxicity Adv Radiat Oncol 5(6) 1104–1105 https://doi.org/10.1016/j.adro.2020.07.013 PMID: 32838072 PMCID: 7428704 18. Cosway B, Douglas L, and Armstrong N, et al (2017) Travelling for treatment; does distance and deprivation affect travel for intensity-modulated radiotherapy in the rural setting for head and neck cancer? J Laryngol Otol 131(6) 546–548 https://doi.org/10.1017/ S0022215117000196 PMID: 28325172 19. Perú, Ministerio de Salud (MINSA) Plan Nacional de Cuidados Integrales del Cáncer (2020–2024) [http://bvs.minsa.gob.pe/local/ MINSA/5341.pdf] Date accessed: 18/07/22 20. Hess LM, Louder A, and Winfree K, et al (2017) Factors associated with adherence to and treatment duration of erlotinib among patients with non-small cell lung cancer J Manag Care Spec Pharm 23(6) 643–652 PMID: 28530522 21. Moelle U, Mathewos A, and Aynalem A, et al (2018) Cervical cancer in Ethiopia: the effect of adherence to radiotherapy on survival Oncologist 23(9) 1024–1032 https://doi.org/10.1634/theoncologist.2017-0271 PMID: 29567823 PMCID: 6192604 22. Jiang W, Wang JY, and Wang JB, et al (2016) Hypofractionated radiotherapy for medically inoperable stage I non-small cell lung cancer Thorac Cancer 7(3) 296–303 https://doi.org/10.1111/1759-7714.12327 PMID: 27148414 PMCID: 4846617 23. Benjamin LC, Tree AC, and Dearnaley DP (2017) The role of hypofractionated radiotherapy in prostate cancer Curr Oncol Rep 19(4) 30 https://doi.org/10.1007/s11912-017-0584-7 PMID: 28343352 PMCID: 5366169 24. Murray Brunt A, Haviland JS, and Wheatley DA, et al (2020) Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FASTForward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial Lancet 395(10237) 1613–1626 https://doi.org/10.1016/S0140-6736(20)30932-6 PMID: 32580883 PMCID: 7262592 Re se ar ch ecancer 2023, 17:1580; www.ecancer.org; DOI: https://doi.org/10.3332/ecancer.2023.1580 9 25. Gamez ME, Agarwal M, and Hu KS, et al (2017) Hypofractionated palliative radiotherapy with concurrent radiosensitizing chemotherapy for advanced head and neck cancer using the “QUAD-SHOT regimen” Anticancer Res 37(2) 685–691 https://doi.org/10.21873/ anticanres.11364 PMID: 28179317 26. Lyu J, Liu T, and Li T, et al (2019) Comparison of efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma Cancer Med 8(8) 3710–3718 https://doi.org/10.1002/cam4.2250 PMID: 31119872 PMCID: